Chaperone-mediated Autophagy Dysfunction in the Pathogenesis of Neurodegeneration

Overview

Journal Neurobiol Dis

Specialty Neurology

Date 2010 Jul 21

PMID 20643207

Citations 45

Authors

Hiroshi Koga

Ana Maria Cuervo

Affiliations

Soon will be listed here.

Abstract

Chaperone-mediated autophagy (CMA) contributes to selective degradation of individual soluble proteins in lysosomes. Unique to this type of autophagy is the fact that proteins reach the lysosomal lumen for degradation by directly crossing the lysosomal membrane, in contrast with the vesicle-mediated delivery characteristic of the other types of autophagy. These two characteristics--selective targeting and direct translocation of substrates--determine the contribution of CMA to different physiological functions and the type of pathological conditions associated with CMA dysfunction. In this review, we briefly revise recent findings on the molecular mechanisms behind CMA function, and describe the physiological relevance of the selective lysosomal degradation through this pathway. We also comment on the cellular consequences of CMA malfunction and on the connections already established between CMA dysfunction and different human disorders, with special emphasis on neurodegenerative diseases. This article is part of a Special Issue entitled "Autophagy and protein degradation in neurological diseases."

Citing Articles

Selective protein degradation through chaperone‑mediated autophagy: Implications for cellular homeostasis and disease (Review).

Huang J, Wang J Mol Med Rep. 2024; 31(1).

PMID: 39513615 PMC: 11542157. DOI: 10.3892/mmr.2024.13378.

Targeted protein degradation: advances in drug discovery and clinical practice.

Zhong G, Chang X, Xie W, Zhou X Signal Transduct Target Ther. 2024; 9(1):308.

PMID: 39500878 PMC: 11539257. DOI: 10.1038/s41392-024-02004-x.

Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies.

Dai L, Liu M, Ke W, Chen L, Fang X, Zhang Z Cell Mol Life Sci. 2024; 81(1):382.

PMID: 39223418 PMC: 11368888. DOI: 10.1007/s00018-024-05419-5.

Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy.

Liu Y, Tan L, Tan M Mol Cell Biochem. 2023; 478(10):2173-2190.

PMID: 36695937 DOI: 10.1007/s11010-022-04640-9.

A bibliometric analysis of autophagy in lung diseases from 2012 to 2021.

Lin F, Chen Y, Mo W, Zhou H, Xiao Z, Hu S Front Immunol. 2023; 13:1092575.

PMID: 36591291 PMC: 9802149. DOI: 10.3389/fimmu.2022.1092575.

References

Ciechanover A . Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol. 2005; 6(1):79-87. DOI: 10.1038/nrm1552. View

Duncan C, Papanikolaou T, Ellerby L . Autophagy: polyQ toxic fragment turnover. Autophagy. 2010; 6(2):312-4. PMC: 2907151. DOI: 10.4161/auto.6.2.11139. View

Larsen K, Sulzer D . Autophagy in neurons: a review. Histol Histopathol. 2002; 17(3):897-908. DOI: 10.14670/HH-17.897. View

Robinson P . Protein stability and aggregation in Parkinson's disease. Biochem J. 2008; 413(1):1-13. DOI: 10.1042/BJ20080295. View

Liu H, Wang P, Song W, Sun X . Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 2009; 23(10):3383-92. DOI: 10.1096/fj.09-134296. View

Agarraberes F, Dice J . A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J Cell Sci. 2001; 114(Pt 13):2491-9. DOI: 10.1242/jcs.114.13.2491. View

Martinez-Vicente M, Talloczy Z, Kaushik S, Massey A, Mazzulli J, Mosharov E . Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest. 2008; 118(2):777-88. PMC: 2157565. DOI: 10.1172/JCI32806. View

Dice J . Chaperone-mediated autophagy. Autophagy. 2007; 3(4):295-9. DOI: 10.4161/auto.4144. View

Smith P, Mount M, Shree R, Callaghan S, Slack R, Anisman H . Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci. 2006; 26(2):440-7. PMC: 6674390. DOI: 10.1523/JNEUROSCI.2875-05.2006. View

10.

Sarkar S, Ravikumar B, Floto R, Rubinsztein D . Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2008; 16(1):46-56. DOI: 10.1038/cdd.2008.110. View

11.

Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow E . Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet. 2009; 18(21):4153-70. PMC: 2758146. DOI: 10.1093/hmg/ddp367. View

12.

Kaushik S, Massey A, Cuervo A . Lysosome membrane lipid microdomains: novel regulators of chaperone-mediated autophagy. EMBO J. 2006; 25(17):3921-33. PMC: 1560360. DOI: 10.1038/sj.emboj.7601283. View

13.

Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

14.

Salvador N, Aguado C, Horst M, Knecht E . Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state. J Biol Chem. 2000; 275(35):27447-56. DOI: 10.1074/jbc.M001394200. View

15.

Cuervo A, Dice J . Regulation of lamp2a levels in the lysosomal membrane. Traffic. 2001; 1(7):570-83. DOI: 10.1034/j.1600-0854.2000.010707.x. View

16.

Cuervo A, Bergamini E, Brunk U, Droge W, Ffrench M, Terman A . Autophagy and aging: the importance of maintaining "clean" cells. Autophagy. 2006; 1(3):131-40. DOI: 10.4161/auto.1.3.2017. View

17.

Bauer P, Goswami A, Wong H, Okuno M, Kurosawa M, Yamada M . Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol. 2010; 28(3):256-63. DOI: 10.1038/nbt.1608. View

18.

Cuervo A, Hildebrand H, Bomhard E, Dice J . Direct lysosomal uptake of alpha 2-microglobulin contributes to chemically induced nephropathy. Kidney Int. 1999; 55(2):529-45. DOI: 10.1046/j.1523-1755.1999.00268.x. View

19.

Kiffin R, Christian C, Knecht E, Cuervo A . Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell. 2004; 15(11):4829-40. PMC: 524731. DOI: 10.1091/mbc.e04-06-0477. View

20.

Koga H, Kaushik S, Cuervo A . Protein homeostasis and aging: The importance of exquisite quality control. Ageing Res Rev. 2010; 10(2):205-15. PMC: 2888802. DOI: 10.1016/j.arr.2010.02.001. View